NCT06715007View on ClinicalTrials.gov

Antiplatelet Therapy and Endothelial-stabilizing Agents in Cerebral Small Vessel Diseases

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

December 20, 2024

Primary Completion Date

December 20, 2025

Study Completion Date

January 20, 2026

Conditions
Stroke, IschemicSmall Vessel Cerebrovascular DiseaseWhite Matter Hyperintensity
Interventions
DRUG

Clopidogrel

Patients will take Clopidogrel

DRUG

Aspirin

Patients will take Rivaroxaban

DRUG

Cilostazol + Isosorbide Mononitrate

Patients will take Cilostazol plus Isosorbide Mononitrate

Trial Locations (1)

210001

RECRUITING

the First affiliated hospital of Nanjing Medical University, Nanjing

All Listed Sponsors
lead

The First Affiliated Hospital with Nanjing Medical University

OTHER